For informational purposes only — not investment advice

← Back to signals

AFRM

LONGINSIDER SELL

AFFIRM HLDGS INC

Research: Finviz ↗·Perplexity ↗

🗄 Viewing archived Q1 2026 data — frozen, no longer refreshed.

Funds
3
Score
3.10
vs SPY
+51.3%
Stock return (since Q-end)
+71.0%
SPY return (since Q-end)
+19.7%
Current price
$78.35
Days to cover (short int.)
3.6d↑+3.9%
as of 2026-09-15

News Summary

Positive

Affirm delivered exceptional Q3 FY2026 results with record GMV of $11.6B (+35% YoY), revenue of $1.04B (+33%), and achieved GAAP operating profitability for the first time as a public company with $102.9M net income. Management raised full-year guidance across GMV, revenue, and margins, outlined a $100B medium-term GMV target with 20-25% GAAP operating margins, and secured major partnership expansions (Google, Royal Caribbean) plus $1.7-2.2B in new funding from CPP Investments. However, Morgan Stanley downgraded the stock from Overweight to Equal Weight on June 25 citing valuation concerns after an 80%+ share price surge, tempering near-term momentum despite affirming long-term conviction.

Red flags

  • •Morgan Stanley downgrade on valuation (stock +80% since March 27) — potential near-term momentum risk
  • •Banking charter application introduces regulatory uncertainty and potential capital/compliance burdens not yet quantified

Funds Buying (3)

FundManagerShares Held∆ SharesPosition Value% of FundQoQStatus
Durable Capital PartnersHenry Ellenbogen5.6M+2.0M$259M2.7%+53%Existing
D1 CapitalDan Sundheim1.9M+1.1M$89M0.8%+136%Existing
Point72Steve Cohen90K+90K$4M<0.1%—NEW

Shares Held and Position Value reflect total quarter-end holdings. ∆ Shares is the change from the prior quarter. % of Fund is the position's share of the fund's reported equity portfolio — it drives the size weighting in the conviction score.

Portfolio Context

Where AFRM ranks in each buying fund's book, and the positions immediately around it. What a holding sits next to often says more about the thesis than the position size does.

Durable Capital Partners

position #15 of this fund's book

  1. 12ROCKET COS INC$275M
  2. 13SHIFT4 PMTS INC$270M
  3. 14VSE CORP$259M
  4. 15AFFIRM HLDGS INC$259M
  5. 16ISHARES TR$255M
  6. 17PRIVIA HEALTH GROUP INC$249M
  7. 18COUPANG INC$243M
D1 Capital

position #38 of this fund's book

  1. 35TAIWAN SEMICONDUCTOR MANUFAC$111M
  2. 36LIVE NATION ENTERTAINMENT IN$103M
  3. 37ANALOG DEVICES INC$93M
  4. 38AFFIRM HLDGS INC$89M
  5. 39FERGUSON ENTERPRISES INC$81M
  6. 40TOPBUILD COR$75M

Values are quarter-end position sizes. Shown only for funds where AFRM ranks inside their 40 largest equity positions — below that, neighbouring names carry no signal. Adjacency is an inference about a fund's reasoning, not a disclosure of it.

Insider Activity

NameTitleTypeSharesPriceValueFiledSrc
Watson Noel Bertram—SELL2K$77.86$0.16M2026-08-12↗
Linford MichaelChief Operating OfficerSELL100K$80.04$8.00M2026-06-26↗
Watson Noel Bertram—SELL2K$65.00$0.13M2026-05-13↗
Watson Noel Bertram—SELL2K$55.00$0.11M2026-04-14↗

Beneficial Ownership (13D/13G)

FilerFormShares% of ClassFiledSrc
BlackRock, Inc.SC 13G14.8M5.1%2026-01-21↗

SC 13D = active intent to influence control (10-day filing deadline after crossing 5%). SC 13G = passive accumulation, no intent to influence control.